1. Volume 58, Issue 5, Pages 2129-2137 (November 2000)
Glomerular permselectivity in early stages of overt diabetic nephropathy 
Steen Andersen, Kristina Blouch, Joan Bialek, Marja Deckert, Hans-Henrik Parving, Bryan D. Myers 
Kidney International 
Volume 58, Issue 5, Pages (November 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Design of the crossover study. Subjects were randomized to 60 days of either placebo (protocol 1) or losartan therapy (protocol 2). This was followed by a 15-day washout period after which each subject crossed over to 60 days of the remaining therapy not given on the first occasion. *Days on which differential solute clearances were performed.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Sieving coefficients (θ) of Ficoll are plotted as a function of Einstein-Stokes radius (ESR). Symbols are: (○) placebo-treated diabetic nephropathy; (▵) controls; *P < 0.05.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Sieving coefficients (θ) of Ficoll in diabetic nephropathy (DN) are plotted as a function of Einstein-Stokes radius (ESR). Symbols are: (○) placebo treatment; (X) losartan treatment. (Δ) P = Data are mean ± SEM.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions